An FDA database analysis shows that reported adverse skin events after GLP-1 receptor agonist use are rare but can include rash and pruritus, highlighting a need for further research, according to a ...
Providing clinicians with access to patient-reported outcome data improves the inter-rater reliability and consistency of ...
Optimizing bispecific AE management in the community requires a combination of standardized clinical protocols, reliable educational tools, and robust communication networks with academic partners.
In patients with diabetes and a prior major adverse limb event, GLP-1s were associated with better outcomes compared with DPP ...
Most common gastrointestinal issues seen were nausea/vomiting, abdominal pain, and diarrhea. HealthDay News — The rate of emergency department visits for adverse events among patients dispensed ...
Background While the incidence of hospital adverse events appeared to be declining before 2019, the COVID-19 pandemic may ...
A new study has exposed "serious adverse events" linked to mifepristone, also known as the "abortion pill." Mifepristone is a "pregnancy blocker" that is used in combination with another medication, ...
When the HSRO approves human-subjects research, the approval is based upon the information about how the research will be conducted and the risks and anticipated benefits to subjects that are known at ...
Nearly 25% of hospital admissions included at least one adverse event, as indicated from data from 2809 admissions at 11 hospitals. The 1991 Harvard Medical Practice Study (HMPS), which focused on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results